Trade Show News News stories include information on domestic and international trade shows and conferences, from guest speakers to schedules to recaps. Releases are posted as available, and may be posted in languages other than English (as originally released).

Latest

Jun 23, 2018, 14:59 ET GCL System Integration stellt hocheffiziente Module auf Intersolar aus

GCL System Integration (SZ: 002506) (GCL-SI), ein Tochterunternehmen des weltweit führenden Clean-Energy-Konzerns GCL Group, stellt seine neuesten...


Jun 23, 2018, 13:46 ET Los módulos de alta eficiencia de GCL System Integration expuestos en Intersolar

GCL System Integration (SZ: 002506) (GCL-SI), una filial de GCL Group, el conglomerado mundial líder en energía limpia, expone actualmente su...


Jun 23, 2018, 13:30 ET One Drop Announces Blood Glucose Prediction and Automated Decision Support

One Drop, a leader in the development of digital therapeutics solutions for people with diabetes, today announced the launch of Blood Glucose...


Jun 23, 2018, 13:01 ET Diabeloop Insulin Delivery System May Significantly Improve Glycemic Control for People with Type 1 Diabetes

New research finds that people with type 1 diabetes (T1D) who used the Diabeloop DBLG1 therapeutic, closed-loop insulin delivery system in a home...


Jun 23, 2018, 12:43 ET Fully Implantable, Continuous Glucose Monitoring Sensor Provided Accuracy for Six Months in Adolescents and Adults with Type 1 Diabetes

When adolescents and adults with type 1 diabetes (T1D) used a new continuous glucose monitoring (CGM) device containing a sensor that can remain...


Jun 23, 2018, 12:43 ET Dual-Hormone, Artificial Pancreas with Insulin and Pramlintide Significantly Improves Glucose Levels, Compared to Insulin-Only Artificial Pancreas

A dual-hormone, artificial pancreas1 delivering rapid insulin and the drug pramlintide improved glucose control and reduced glucose variability in...


Jun 23, 2018, 12:40 ET Omnipod® Hybrid Closed-Loop Insulin Delivery System Significantly Improves Glycemic Control in Adults with Type 1 Diabetes

Adults with type 1 diabetes using the Omnipod hybrid closed-loop system (the Horizon™ Automated Glucose Control System) were studied in a...


Jun 23, 2018, 12:19 ET Hanergy stellt seine jüngsten Innovationen auf der Intersolar Europe aus

Unternehmen präsentiert mit dem Hantile und dem Humbrella bahnbrechende Produkte Die Hanergy Holding Group, ein multinationales Unternehmen,...


Jun 23, 2018, 10:51 ET Des modules à haut rendement de GCL System Integration exposés à l'Intersolar

GCL System Integration (SZ: 002506) (GCL-SI), une filiale du plus grand conglomérat mondial de l'énergie propre, GCL Group, exposera ses tout...


Jun 23, 2018, 10:12 ET Tresiba® demonstrated significantly lower A1C and rates of hypoglycaemia versus insulin glargine U-300 in real-world evidence study

Findings from CONFIRM – a large, retrospective real-world evidence (RWE) study comparing the effectiveness of Tresiba® (insulin degludec injection)...


Jun 23, 2018, 10:09 ET Ozempic® provided greater weight reductions for adults with a baseline BMI ≥25kg/m2 than those with lower baseline BMI <25kg/m2, in a SUSTAIN 7 post-hoc analysis

Ozempic® (semaglutide) injection 0.5 mg or 1 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with...


Jun 23, 2018, 10:06 ET Oral semaglutide demonstrated significant reduction in blood sugar vs placebo in PIONEER 1 trial

Oral semaglutide, an investigational GLP-1 receptor agonist taken as a once-daily tablet, achieved significant reductions in blood sugar versus...


Jun 23, 2018, 10:00 ET Real-World Evidence Shows Oral INVOKANA® (canagliflozin) Results in Greater Weight Loss and Treatment Adherence Than Injectable GLP-1 Receptor Agonists in Type 2 Diabetes Patients

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new findings from two real-world studies comparing sodium glucose...


Jun 23, 2018, 10:00 ET New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce Potential of Lilly's Ultra Rapid Lispro in People with Type 1 and Type 2 Diabetes

Eli Lilly and Company's (NYSE: LLY) ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1...


Jun 23, 2018, 10:00 ET Jardiance® reduced risk of kidney disease progression in adults with type 2 diabetes and established cardiovascular (CV) disease independent of control of conventional CV risk factors

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced findings from two new analyses of the landmark EMPA-REG OUTCOME® trial,...


Jun 23, 2018, 09:47 ET Gaumard's Growing Family Takes Center Stage at AWHONN '18

With women's health, obstetric and neonatal nurses taking on ever-greater responsibilities, there's no better time than AWHONN's 2018 annual...


Jun 23, 2018, 08:05 ET Significant blood sugar improvement with Xultophy® 100/3.6 compared to insulin glargine U-100 when used as add-on to oral diabetes medications

Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL provided superior A1C reduction compared to insulin...


Jun 23, 2018, 08:00 ET Two-year Data from ViaCyte's STEP ONE Clinical Trial Presented at ADA 2018

ViaCyte, Inc., a privately-held regenerative medicine company, today announced two-year data from Cohort 1 of the ongoing Safety, Tolerability, and...


Jun 23, 2018, 08:00 ET Investigational Doses of Lilly's Once-Weekly Trulicity® (dulaglutide) Show Promise in Delivering Powerful Efficacy in People with Type 2 Diabetes

Two investigational doses of Lilly's dulaglutide (4.5 mg and 3.0 mg), as well as Trulicity® (dulaglutide) 1.5 mg, provided significantly better...


Jun 23, 2018, 08:00 ET New Data Show Amgen's Repatha® (evolocumab) Significantly Reduced LDL-C And Non-HDL-C In High-risk Patients With Type 2 Diabetes

Amgen (NASDAQ:AMGN) today announced new data that show Repatha® (evolocumab) significantly reduced low-density lipoprotein cholesterol (LDL-C) and...


Jun 22, 2018, 18:37 ET TBWA\Worldwide Wins Big At 2018 Cannes Lions International Festival Of Creativity

TBWA\Worldwide delivered one of its best performances in years at the Cannes Lions International Festival of Creativity, winning Gold or higher in...


Jun 22, 2018, 18:30 ET Founder World 2018: Blockchain Impact announced by F50 and Silicon Valley's Blockchain Developer and Founder Communities @ the Blockchain Developer Hackathon in Silicon Valley

Silicon Valley Blockchain Developer Hackathon -- F50, Blockchain Founder Club, and Silicon Valley Entrepreneurs & Startup (SVE), announced...


Jun 22, 2018, 17:37 ET Vysoce výkonné moduly společnosti GCL System Integration jsou prezentovány na výstavě Intersolar

GCL System Integration (SZ: 002506) (GCL-SI), dceřiná společnost největšího světového koncernu GCL Group pro čistou energii, prezentuje své...


Jun 22, 2018, 16:30 ET Ketchum and its Clients Win 30 Lions at 2018 Cannes Lions International Festival of Creativity

Leading global communications consultancy Ketchum was honored with 30 Cannes Lions for its work on behalf of its clients, including the Titanium...